Structural and Functional Aspects of Rat Microsomal Glutathione Transferase
THE ROLES OF CYSTEINE 49, ARGININE 107, LYSINE 67, HISTIDINE, AND TYROSINE RESIDUES*

(Received for publication, December 11, 1996)

Rolf Weinander Dagger §, Lena Ekström Dagger , Claes Andersson Dagger , Haider Raza , Tomas Bergman par and Ralf Morgenstern Dagger **

From the Dagger  Institute of Environmental Medicine, Division of Biochemical Toxicology, Karolinska Institutet, Box 210, S-171 77 Stockholm, Sweden and the par  Department of Medical Biochemistry and Biophysics, Karolinska Institutet, S-171 77 Stockholm, Sweden

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

Rat liver microsomal glutathione transferase is rapidly inactivated upon treatment with the arginine-selective reagent phenylglyoxal or the lysine-selective 1,3,5-trinitrobenzenesulfonate. Glutathione sulfonate, an inhibitor of the enzyme, gives nearly complete protection against inactivation and prevents modification, indicating that these residues form part of or reside close to the active site. Sequence analysis of peptides from peptic and tryptic digests of [7-14C]phenylglyoxal- and 1,3,5-trinitrobenzenesulfonate-treated microsomal glutathione transferase indicated arginine 107 and lysine 67 as the sites of modification. A set of mutant forms of microsomal glutathione transferase was constructed by site-directed mutagenesis and heterologously expressed in Escherichia coli BL21(DE3). Arginine 107 was exchanged for alanine and lysine residues. The alanine mutant (R107A) exhibited an activity and inhibition profile similar to that of the wild type enzyme but displayed a decreased thermostability. Thus, arginine 107 does not appear to participate in catalysis or substrate binding; instead, an important structural role is suggested for this residue. Lysine 67 was mutated to alanine and arginine with no effect on activity. All three histidines were replaced by glutamine, and the resulting mutant proteins had activities comparable with that of the wild type. It can thus be concluded that the chemical modification experiments indicating that arginine 107, lysine 67, and one of the histidines partake in catalysis can be disproved. However, protection from modification by a competitive inhibitor indicates that these residues could be close to the glutathione binding site. All tyrosine to phenylalanine substitutions resulted in mutants with activities similar to that of the wild type. Interestingly, the exchange of tyrosine 137 appears to result in activation of the enzyme. Thus, the microsomal glutathione transferase must display an alternate stabilization of the thiolate anion of glutathione other than through interaction with the phenolic hydroxyl group of a tyrosine residue. Substitution of cysteine 49 with alanine resulted in a semiactivated mutant enzyme with enzymatic properties partly resembling the activated form of microsomal glutathione transferase. The function of this mutant was not altered upon reaction with N-ethylmaleimide, and cysteine 49 is thus demonstrated as the site of modification that results in activation of microsomal glutathione transferase.


INTRODUCTION

Microsomal glutathione transferase (1) is a membrane-bound member of the glutathione transferase family of enzymes (2). Glutathione transferases (GSTs)1 are a group of phase II detoxication enzymes that catalyze the conjugation of glutathione to a variety of molecules bearing different electrophilic centers, which are all hydrophobic (3). Thus, the GSTs aid in the detoxication of numerous carcinogenic, toxic, and pharmacologically active substances (3). The transferases exist as multiple cytosolic isoforms with molecular mass values in the 24-28-kDa region (4-6) and a membrane-bound microsomal GST. Rat microsomal GST has a molecular mass of 17.3 kDa with an amino acid sequence analyzed both at the protein and cDNA level (7, 8). Microsomal GST is present at the highest levels in the liver and has been purified from rat (9), mouse (10), and human (11). These species express closely related enzymes. In contrast to the cytosolic GSTs, which are dimeric proteins, the microsomal transferase is a trimer that contains one single cysteine residue per subunit (7, 12). The microsomal GST is activated in vitro by various treatments such as covalent modification of cysteine 49 by sulfhydryl reagents (13), limited proteolysis (14), heating (15), and reactive oxygen species (16). Activation by sulfhydryl reagents or proteolysis has not been observed with cytosolic GSTs.

Three-dimensional structures of cytosolic GSTs from the Alpha (17), Mu (18), Pi (19), Theta (20), and Sigma (21) classes have been characterized. The projection structure of the membrane-bound, structurally distinct microsomal GST has been solved at 4-Å resolution (12). A previous investigation utilizing chemical modification with selective reagents indicated the importance of arginine, lysine, and histidine residues for the catalytic function of rat microsomal GST (22). In many cytosolic GSTs studied, a tyrosine residue has been identified as having a critical role in catalysis by stabilizing the nucleophilic thiolate anion of the enzyme-bound GSH molecule. This activation of the thiol is suggested to occur by the phenolic hydroxyl group of the tyrosine residue (or serine hydroxyl in Theta class enzymes) interacting with the sulfur of GSH (23-26). Clearly, it is of interest to investigate a possible similar function of a tyrosine residue in the microsomal GST as well as the role of cysteine for activation. The development of heterologous expression and purification of recombinant microsomal GST from Escherichia coli has opened new possibilities to examine the structure and function of this enzyme by site-directed mutagenesis.

In this study, we have investigated whether amino acids previously implicated in catalysis or activation could be verified or excluded. Some of the results have been communicated in a preliminary form (27, 28).


EXPERIMENTAL PROCEDURES

Materials

Phenylglyoxal and 1,3,5-trinitrobenzenesulfonate (TNBS) were obtained from Sigma. [7-14C]Phenylglyoxal and [alpha -35S]dATP were purchased from Amersham (United Kingdom). Pepsin was purchased from Worthington (Freehold, NJ). Trypsin (L-1-tosylamido-2-phenylethyl chloromethyl ketone-treated) and lysozyme were from Boehringer (Mannheim, Germany). Plasmid DNA isolation and gel extraction kits were from Qiagen (Germany). DNA sequencing kit was from U.S. Biochemical Corp. Media and buffers for bacteria and DNA experiments were prepared as described (29). All other chemicals were of highest purity and obtained from common commercial sources.

Methods

Enzyme Purification

Microsomal glutathione transferase was purified from male Sprague Dawley rat livers as described previously (13). Glutathione was removed from the purified enzyme as described by Weinander et al. (30) or by ion exchange chromatography. For the latter procedure, the enzyme was diluted in 10 volumes of 10 mM potassium phosphate, pH 7.0, 0.1 mM EDTA, 1% Triton X-100, 20% glycerol (v/v), and 1 mM GSH (buffer A) and applied to a CM-Sepharose cation exchange column equilibrated with the same buffer. The column was washed with 5 volumes of buffer A devoid of GSH, and the glutathione-free enzyme was eluted by the addition of 0.2 M KCl in buffer A. Removal of GSH was checked as described (30).

Enzyme Assays

Enzyme activities with 1-chloro-2,4-dinitrobenzene (CDNB; 0.5 mM) were assayed at 340 nm in 0.1 M potassium phosphate, pH 6.5, containing 0.1% Triton X-100 at 30 °C (31). When activity was determined in bacterial membranes and crude fractions, the concentration of Triton X-100 was increased to 1% to avoid an increase in turbidity. The activity with 4-chloro-3-nitrobenzamide was determined at 370 nm as described (32). The activity of C49A with N-acetyl-L-cysteine and CDNB was determined with the partially purified enzyme where GSH had been removed by the addition of 5 mM N-ethylmaleimide (NEM) and 5-min incubation on ice. C49A lacks thiol groups, and incubation with NEM did not have any effect on the activity of this mutant with any substrate used. Although it could not be completely excluded, the possible inhibition by the presence of GS-NEM product in the assay did not appear to be of any importance (the activities were linear with added enzyme). kcat/Km for C49A was determined directly with one substrate saturating and the other at low concentration under first order conditions. When inhibition was studied, the substrates and enzyme were first mixed, and the control activity was determined (approximately 20 s) followed by the addition of inhibitor. All assays were repeated at least three times, and all background rates were subtracted. Thermostability was determined by placing an aliquot of enzyme at room temperature (approximately 24 °C). GST activity was assayed at the time points indicated in Fig. 3.


Fig. 3. Thermostability of microsomal GST at room temperature (24 °C). Enzyme was incubated at room temperature, and aliquots were withdrawn and assayed for activity at the time points indicated. triangle , wild type, unactivated; black-triangle, wild type, NEM-activated; black-square, R107A, unactivated; square , R107A, NEM-activated; bullet , R107A, unactivated plus N-acetyl-L-cysteine as thiol substrate.
[View Larger Version of this Image (12K GIF file)]


Activation of Microsomal Glutathione Transferase

Activation of the purified enzyme with 2-5 mM NEM was performed at 4 °C in 10 mM potassium phosphate, pH 8.0, 0.1 mM EDTA, 1% Triton X-100, 20% glycerol (v/v), 1 mM GSH, and 0.1 M KCl. When maximal activity was reached (within 5 min), the reaction was terminated by the addition of GSH to give a final concentration of the free thiol of approximately 1 mM. The GSH-free enzyme was activated by the addition of 0.5 mM NEM. Carry-over of NEM to the assay had only marginal effects on the GSH concentration (<0.5%).

Modification of Arginine Residues

Purified glutathione-free microsomal GST (about 2 mg/ml) in buffer A was treated with 0.5 mM NEM and mixed with an equal amount of 0.2 M potassium phosphate, pH 8.0. The modification reaction was then started by the addition of 5 mM phenylglyoxal (PG) dissolved in 50% ethanol. The incubation contained 2.5% (v/v) ethanol (final concentration), which did not influence control activity. Reactions were performed at room temperature in the absence and presence of 2 mM glutathione sulfonate, respectively. Aliquots were withdrawn for assay at time points indicated in Fig. 1.


Fig. 1. a, inactivation of microsomal glutathione transferase by phenylglyoxal (5 mM), in the absence (square ) and presence of 2 mM glutathione sulfonate (black-triangle). b, inactivation of microsomal glutathione transferase by 1,3,5-trinitrobenzenesulfonate (0.5 mM), in the absence (open circle ) and presence of 2 mM glutathione sulfonate (bullet ). Experimental details are described under "Methods."
[View Larger Version of this Image (10K GIF file)]


Stoichiometry of Modification

8 nmol of glutathione-free, NEM-treated microsomal glutathione transferase was incubated with 14C-labeled PG (1100 cpm/nmol) in a volume of 200 µl of 50% buffer A, 50% 0.2 M potassium phosphate, pH 8.0, at room temperature in the absence and presence of 2 mM glutathione sulfonate. 30-µl aliquots of the reaction mixture were withdrawn after 0, 0.5, 1, 2, 5, 10, 20, and 30 min and precipitated in 10% trichloroacetic acid. The precipitated enzyme was pelleted and washed three times with 1 ml of 10% trichloroacetic acid. Pellets were dissolved in 0.1 ml of formic acid, and the amounts of PG incorporated were determined by scintillation counting. In parallel incubations, 5 mM PG was added at room temperature in the absence and presence of 2 mM glutathione sulfonate, and the activity versus time was determined.

Proteolytic Digestion, Peptide Separation, and Identification of Reagent-modified Enzyme

300 nmol of microsomal GST (glutathione-free and NEM-treated) was reacted with 20 µCi of [14C]PG in a volume of 4 ml of the buffer described above in the absence and presence of 2 mM glutathione sulfonate, respectively. The final concentration of PG in the mixture was 5 mM. Reactions were carried out at room temperature for 25 min, whereafter 10 µl of the respective mixture was assayed for GST activity to ensure that inactivation/protection was complete. Detergent and free PG was removed from the protein by cation exchange chromatography on a Sep Pak Accell Plus CM column (Waters) that had been equilibrated with buffer A. The column was washed with 5 mM potassium phosphate followed by water. The enzyme was eluted with 4 × 1 ml of formic acid, and the two fractions with the highest protein content (as determined by absorption at 280 nm) were pooled and dried under N2. Thereafter, the enzyme was dissolved in 100 µl of formic acid and digested by pepsin (0.25 mg/ml) in a volume of 2 ml of 5% formic acid at 37 °C overnight. The resulting peptide mixtures were dried with N2 and dissolved in 0.5 ml of formic acid.

Peptides were purified by reverse-phase HPLC on a CT-sil C-18 column (5 µm, 4.6 × 250 mm). The solvent system consisted of 0.1% trifluoroacetic acid/acetonitrile with a linear gradient of 0-5% acetonitrile over 10 min followed by 5-50% acetonitrile over 110 min and, thereafter, 50-80% acetonitrile over 10 min. Elution was monitored at 214 nm, and the flow rate was 1 ml/min. Peak fractions were collected manually, and the radioactivity in each fraction was determined by scintillation counting of a 25-µl aliquot. Fractions containing the peak radioactivities were rechromatographed on the same column using the same solvent system. Fractions containing the radioactive peptides from this second round of chromatography were sequenced as described below. 50% of the obtained amino acid phenylthiohydantoin derivatives were subjected to amino acid identification, and 50% were taken for scintillation counting.

Modification of Lysine Residues

Purified glutathione-free, NEM-treated microsomal GST (about 2 mg/ml) was mixed with an equal amount of 0.2 M potassium phosphate, pH 7.0. The reaction was started by the addition of 0.5 mM TNBS dissolved in 0.2 M potassium phosphate, pH 7.0. Incubation was performed at room temperature in the absence/presence of 2 mM glutathione sulfonate, and aliquots were withdrawn for assay at the time points indicated in Fig. 1. To ensure that protection of the enzyme activity by glutathione sulfonate was not a result of reaction of the inhibitor and TNBS, the reaction rate of 0.5 mM TNBS and 2 mM glutathione sulfonate was determined at 345 nm, assuming a molar extinction coefficient for the reaction product of 1.1 × 104 M-1 cm-1 (33). In all experiments, this rate was very low, and the possibility that glutathione sulfonate gave protection by reacting with and depleting TNBS could thus be excluded.

Stoichiometry of Modification

Approximately 5 nmol of glutathione-free, NEM-treated microsomal GST was incubated with 0.5 mM TNBS in a volume of 100 µl of 50% buffer A, 50% 0.2 M potassium phosphate, pH 7.0, in the absence and presence of 2 mM glutathione sulfonate at room temperature. 20-µl aliquots of the reaction mixture were withdrawn after 0, 0.5, 1, 5, 10, 20, and 30 min, denatured, and dissolved in 5% formic acid. The number of trinitrophenylated amino groups was determined from the absorbance at 345 nm using a molar extinction coefficient of 1.1 × 104 M-1 cm-1 (33).

Proteolytic Digestion, Peptide Separation, and Identification of TNBS-modified Enzyme

150 nmol of glutathione-free, NEM-treated microsomal GST was reacted with 0.5 mM TNBS in the absence and presence of 2 mM glutathione sulfonate. The reactions were performed in a volume of 3 ml of the buffer described above for 20 min at room temperature. A 10-µl aliquot of the respective mixture was withdrawn for assay of the inactivation/protection. Reactions were terminated by the addition of 0.5 M L-lysine, and the mixtures were dialyzed against 0.4 M Tris-HCl, pH 8.0, 2 mM EDTA, 8 M urea until all Triton X-100 was removed from the solutions as determined from the decrease in absorbance at 275 nm. Thereafter, the mixtures were dialyzed against H2O for 48 h. The protein was digested by trypsin (1:50, w/w) in 50 mM ammonium bicarbonate at 37 °C for 5 h. Peptide mixtures were dried with N2 and dissolved in 0.5 ml of formic acid.

Peptides were purified by reverse-phase HPLC using the same system as described above with a linear gradient of 0-80% acetonitrile over 45 min. Elution was monitored at 214 and 345 nm. Peak fractions were collected manually, and the fraction containing the peak absorbance at 345 nm was subjected to sequence analysis.

Amino Acid Sequence Analysis

The amino acid sequence of the peptides was determined by automated Edman degradation using an Applied Biosystems 470 A instrument. Amino acid phenylthiohydantoin-derivatives were analyzed by reverse-phase HPLC as described (34).

Site-directed Mutagenesis

The plasmid pSP19T7LTrµGT, in which cDNA coding for wild type rat microsomal GST has been ligated (35), was used as a template for site-directed mutagenesis utilizing PCR. Oligonucleotide primers used to construct mutants are shown in Table I. To construct K67A and K67R, the PCRs were performed with the primer rU1, which contains the sense sequence of the 5'-end of the coding region of the microsomal GST cDNA and the respective antisense primer directing the Lys67 mutations. The PCR products were digested with NdeI and MluI, gel-purified, and ligated into the vector pSP19T7LTrµGT that had been cut with NdeI and MluI and gel-purified.

Table I.

Oligonucleotide primers used to construct mutant forms of rat microsomal GST


Primer Sense Sequencea Amino acid changed

K67A Inverse 5'-TCGCACGCGTTCCACCTCGTCAGTC-3' Lys67  right-arrow Ala
K67R Inverse 5'-TCGCACGCGTTCCACCTCGTCAGTC-3' Lys67  right-arrow Arg
R107A Inverse 5'-TCCGAGCGCCCACAAAGATGAAGTGAATG-3' Arg107  right-arrow Ala
R107K Inverse 5'-TCCGAGCGCCCACAAAGATGAAGTGAATG-3' Arg107  right-arrow Lys
C49A Forward 5'-GCCAACCCGGAAGACGCTGGCTTC-3' Cys49  right-arrow Ala
H75Q Forward 5'-GAAGAGCCCTGAATGA-3' His75  right-arrow Gln
H105Q Inverse 5'-TCCGAGCGCCCACAAAGATTCTGAAAATGAG-3' His105  right-arrow Gln
H116Q Forward 5'-GGATCTACACCATTGC-3' His116  right-arrow Gln
Y92F Inverse 5'-GATCCGGTCCGCTCAGGGACAGGAGGC-3' Tyr92  right-arrow Phe
Y115F Forward 5'-TGTGGGCGCTCGGATCCACACCATT-3' Tyr115  right-arrow Phe
Y120F Forward 5'-TGTGGGCGCTGCGATCTACCACACCATTGCTTTGACTCCC-3' Tyr120  right-arrow Phe
Y137F Forward 5'-GTTGGCGGAGTTA-3' Tyr137  right-arrow Phe
Y145F Forward 5'-ACGGAGTTACTTTGTCAATGGCTAGGCTGCTC-3' Tyr145  right-arrow Phe
Y153F Inverse 5'-CGAAGCTTATTACAACAGTCTGCT-3' Tyr153  right-arrow Phe
rU1 Forward 5'-CGCATATGGCTGACCTCAAG-3'
rL Inverse 5'-CGAAGCTTATTACAAGTACAGTCTG-3'

a The mismatches to wild type directing the codon changes are underlined.

The Arg107 mutations and H105Q were constructed in a PCR with the respective antisense mutagenic primer against rU1. Products were digested with NdeI and HhaI, gel-purified, and ligated in a mixture with the vector pSP19T7LT that had been cut with NdeI and HindIII and a DNA segment coding for the C-terminal part of wild type rat microsomal GST, which had been cut with HhaI and HindIII.

To introduce the mutations C49A, H75Q, H116Q, Y115F, Y120F, Y137F, and Y145F, the PCRs were made with the respective mutagenic sense primers and the antisense primer rL, which contains the 3'-end of the coding region. The resulting PCR products were gel-purified and thereafter used as mutagenic "megaprimers" in a second PCR against rU1. Y92F and Y153F were also constructed with the "megapriming" technique. In this case, the antisense mutagenic primers were used in PCRs together with the sense primer rU1, and the products were subsequently used as megaprimers against rL in the second PCR.

All products from this second PCR were digested with NdeI and HindIII, gel-purified, and ligated into the expression vector pSP19T7LT that had been cut with NdeI and HindIII.

PCRs were performed with 0.2 mM dNTPs, 2 mM MgCl2, a 0.25 µM concentration of the respective primer, about 0.1 pmol of template, and 0.5 units of Vent (New England Biolabs, Beverly, MA) or Pfu (Stratagene, La Jolla, CA) polymerase. The temperature cycles were 30 s at 94 °C, 1 min at 40 °C, and 2 min at 72 °C, repeated 10 times followed by 30 s at 94 °C, 1 min at 50 °C, and 2 min at 72 °C, repeated 20 times. The reaction was terminated by a 7-min extension at 72 °C.

All constructs were transformed into competent E. coli JM-109 or XL-1 Blue as described (36), positive clones were identified, and the plasmids were isolated. The inserts were sequenced by the chain termination method of Sanger et al. (37), and plasmids containing the desired mutations were transformed into E. coli BL 21 (DE 3) (that contained the plasmid pLysSL (38)). Glycerol stocks were prepared and stored frozen at -70 °C for subsequent use as starting material for the expression experiments.

Expression of Microsomal GST in E. coli BL 21 (DE 3) and Isolation of Membranes

A small aliquot (1-2 µl) of bacterial glycerol stock was grown in 1.5 ml of 2 × YT overnight at 37 °C. The culture was diluted 1:100 in TB (terrific broth) and grown until the A600 was 0.4-1.2. At this point, the temperature was switched to 30 °C, and expression was induced by the addition of 0.4 mM isopropyl beta -D-thiogalactopyranoside, followed by another 4 h shaking (250 rpm) of the culture. All steps were performed in the presence of ampicillin (75 µg/ml) and chloramphenicol (10 µg/ml). Thereafter, cells were pelleted and resuspended in TSEG buffer (15 mM Tris-HCl, pH 8.0, 0.25 M sucrose, 0.1 mM EDTA, 1 mM GSH). The cells were lysed by sonication using four 30-s pulses from a MSE Soniprep 150 sonifier at 40-60% of maximum power. Cell debris was removed by centrifugation at 5000 × g for 10 min. The supernatant was then centrifuged at 250,000 × g for 60 min, and the membrane pellets were suspended in 10 mM potassium phosphate, pH 7.0, 20% glycerol, 0.1 mM EDTA, 1 mM GSH.

Expression and Partial Purification of Recombinant Microsomal GST Mutants

Overnight cultures were prepared as described above and diluted into 3 liters of TB containing ampicillin (75 µg/ml) and chloramphenicol (10 µg/ml) in a 5-liter flask placed in a thermostated water bath. The expression of mutant microsomal GST was induced, and the culture was grown under the same conditions as described above except that oxygenation was provided by air bubbling instead of shaking. After the cells were pelleted and resuspended, lysozyme was added to a final concentration of 0.2 mg/ml, and the mixture was gently stirred for 30 min at 4 °C. The resulting spheroplasts were pelleted (8000 × g, 10 min), resuspended in TSEG buffer, and lysed by sonication as described above. Magnesium chloride was added to a final concentration of 6 mM, and DNA and RNA were hydrolyzed by DNase I (4 µg/ml) and RNase A (4 µg/ml) for an additional 30 min at 4 °C with gentle stirring. Membranes were prepared as described above and solubilized by the addition of an equal volume of 10 mM potassium phosphate, pH 7.0, 20% glycerol, 0.1 mM EDTA, 1 mM GSH, and 10% Triton X-100. Insoluble particles were removed by centrifugation (100,000 × g, 20 min). Partial purification of recombinant mutant microsomal GST was performed as follows. Solubilized membranes were adsorbed to 30 g of hydroxyapatite (Bio-Gel HTP, Bio-Rad) equilibrated with buffer A for 15 min. Hydroxyapatite elution was performed by a batch procedure where the hydroxyapatite was pelleted by a low speed centrifugation pulse and washed with 2 volumes of buffer A, followed by 1 volume of 50 mM potassium phosphate in buffer A. Recombinant mutant enzyme was eluted with 0.4 M potassium phosphate in buffer A and desalted by dialysis for 20 h against 30 volumes of buffer A. Further purification was performed by ion exchange chromatography on a 5-ml HiTrap SP column (Pharmacia, Sweden) equilibrated with buffer A. The enzyme was eluted by a linear gradient of 1 M KCl in buffer A, and 1-ml fractions were collected at a flow rate of 2.5 ml/min. Microsomal GST content of the fractions was determined by measurement of GST activity. Solubilization and purification was performed at 4 °C. Fractions with peak activity were analyzed by gel electrophoresis and Coomassie Blue staining. Since it was evident that a completely pure protein had not been obtained, the amounts of microsomal GST in peak fractions were determined by Western blots as described below.

Gel Electrophoresis of Proteins

Sodium dodecyl sulfate polyacrylamide gel electrophoresis was performed according to Laemmli (39) in 15% polyacrylamide gels. Gels were stained with Coomassie Brilliant Blue R-250. Western blots and immunodetection with specific antisera toward the rat liver enzyme were performed as described (40). Polyclonal antibodies raised toward a synthetic peptide composed of amino acid residues 41-52 of rat microsomal GST were used for the detection of mutants, since the antisera directed toward full-length protein reacted differently with the mutants. For the detection of C49A, polyclonal antisera directed against full-length microsomal GST where the antibodies reacting with this specific domain had been removed by the addition of an excess of the peptide described above were used. Purified rat microsomal GST was used as standard. Rainbow marker molecular weight standards were from Amersham.

Protein Determination

Protein was determined by the method of Peterson (41) with bovine serum albumin as standard.


RESULTS

Inactivation by Phenylglyoxal

Microsomal GST is rapidly inactivated by 5 mM PG at pH 8.0 (Fig. 1a). Inclusion of the substrate analogue and inhibitor glutathione sulfonate provided almost complete protection against inactivation (Fig. 1a). The stoichiometry of inactivation was examined by calculating the incorporation of [7-14C]PG into protected and unprotected enzyme. 1.7 mol of PG is incorporated per mol of unprotected enzyme, while 0.8 mol of PG is incorporated per mol of protected enzyme (Fig. 2a). Microsomal GST was reacted with [14C]PG in the presence and absence of glutathione sulfonate and digested by pepsin. The digests were separated on a C-18 reverse-phase column. Two major radioactive peaks that were preferentially labeled in the absence of glutathione sulfonate appeared in the HPLC chromatogram (not shown). Sequence determination of one of these peaks identified Arg107 as X in X-Ile-Phe-Val-Gly, where the first amino acid phenylthiohydantoin-derivative released had high radioactivity and eluted at a retention time that did not correspond with any amino acid standard phenylthiohydantoin-derivative (12.8 min compared with 11.8 min for phenylthiohydantoin-arginine). This sequence is identical to that from Arg107 to Gly111 of microsomal GST. The other peak consisted of a mixture of peptides where no residue could be unambiguously identified. These observations therefore suggest Arg107 to be the essential residue modified by PG.


Fig. 2. a, modification of arginine residues of microsomal glutathione transferase as determined by the incorporation of [7-14C]phenylglyoxal in unprotected and glutathione sulfonate-protected enzyme. b, modification of lysine residues of microsomal glutathione transferase as determined by the incorporation of 1,3,5-trinitrobenzenesulfonate in unprotected and glutathione sulfonate-protected enzyme. Experimental details are described under "Methods."
[View Larger Version of this Image (23K GIF file)]


Site-directed Mutagenesis of Arg107

To further investigate the role of Arg107, the arginine was replaced with alanine and lysine residues by site-directed mutagenesis. The mutant enzymes were expressed in E. coli BL21(DE3), and recombinant enzyme content and activities were determined in the bacterial membrane fractions. A recombinant protein was expressed in the bacterial membrane in both cases. R107A exhibited a very low, almost undetectable activity (Table II). The amounts expressed of this mutant were considerably lower, although the majority was recovered in the membrane fraction and no increase in formation of inclusion bodies could be observed. R107K, on the other hand, where the arginine is replaced by lysine, exhibits a behavior indistinguishable to the wild type enzyme. An electrostatic interaction, involving the side chain of Arg107 is therefore implicated in the function of microsomal GST.

Table II.

Enzyme activity of site-directed mutants of microsomal GST with CDNB as electrophilic substrate

Activity was determined in bacterial membranes as described under "Methods," and the values shown are from a typical experiment.


Mutation Specific activity with CDNB

µmol min-1 mg-1
Wild type 3.5
K67A 5.0
K67R 2.5
R107A NDa
R107K 2.2
H75Q 1.2
H105Q 1.5
H116Q 0.7
C49A 6.4
Y92F 3.8
Y115F 2.6
Y120F 1.7
Y137F 13
Y145F 2.6
Y153F 2.4

a ND, Not detected. No activity above background could be observed.

Partial Purification of R107A

Solubilization of bacterial membranes with Triton X-100 followed by hydroxyapatite and ion exchange chromatography yielded a partially pure mutant enzyme. The elution profile was similar to wild type microsomal GST, but the yield was lower, and a completely pure protein could not be recovered. Quite surprisingly, it then became apparent that R107A actually exhibits an activity very similar to that of the wild type enzyme. Specific activities with CDNB were 4.2 ± 0.6 µmol min-1 mg-1 for the unactivated and 24 ± 6 µmol min-1 mg-1 for the NEM-treated enzyme, respectively (means ± S.D.). Like the wild type microsomal GST, R107A is also active toward N-acetyl-L-cysteine with a specific activity of 1.5 µmol min-1 mg-1 for the unactivated mutant. Also, inhibition characteristics of R107A were identical to those of the wild type control and consistent with earlier reports of inhibition of microsomal GST (not shown). The difficulties in determining the enzyme activity of R107A in membrane fractions are probably a result of the low amounts expressed perhaps combined with a lower stability. In fact, these observations could be explained by a dramatic decrease in thermostability of R107A, since gradual and irreversible loss of enzyme activity results when R107A is simply left to stand at room temperature. The wild type microsomal GST is virtually unaffected (Fig. 3). When wild type enzyme was reacted with PG on ice, no significant decrease of activity was observed, not even when the incubation time was prolonged to 2 h to compensate for the presumed lower rate of reaction at 0 °C (Fig. 4). However, as soon as the mixture was shifted to room temperature (24 °C), the enzyme was inactivated in a time course indistinguishable from that observed for R107A (Figs. 3 and 4). R107A thus exhibits a behavior much like the PG-modified microsomal GST, and Arg107 most likely is essential for conformational stability. It is highly interesting to note that the PG-modified (30) and mutated (R107A) enzyme forms (the latter after thermal denaturation (Fig. 3)) both retain >= 50% of the activity toward N-acetyl-L-cysteine. A conformational change rather than complete denaturation is thus indicated.


Fig. 4. Thermostability of phenylglyoxal-modified microsomal GST. square , control; black-square, with PG at room temperature; black-triangle, with PG on ice. The arrow indicates the time of withdrawal to room temperature. Experimental details are described under "Methods."
[View Larger Version of this Image (10K GIF file)]


Inactivation by TNBS

Incubation of microsomal GST with 0.5 mM TNBS resulted in rapid, near complete loss of activity, and glutathione sulfonate provided very good protection (Fig. 1b). The stoichiometry of trinitrophenylation of the microsomal GST was measured by the absorbance increase at 345 nm. Assuming that the modified amino acid residue is 2,4,6-trinitrophenyl-lysine, two lysine residues were found to be modified upon inactivation. Glutathione sulfonate protected one of these residues (Fig. 2b).

Tryptic digests of microsomal GST reacted with 0.5 mM TNBS in the presence and absence of glutathione sulfonate were analyzed by reverse-phase HPLC on a C-18 column. The elution of peptides containing trinitrophenylated residues was monitored directly by the absorbance at 345 nm. One distinct peak that had high absorbance at 345 nm appeared. When glutathione sulfonate was present in the modification reaction, this peak was almost undetectable. The labeled fraction was subjected to amino acid sequence analysis. Although not completely pure, one major peptide sequence could be clearly identified as Thr-Asp-Glu-X-Val-Glu-Arg. This sequence corresponds to that of residues 64-70 in the microsomal GST except that the lysine in position 67 was undetectable. In this position, a derivative with much longer retention time than any of the phenylthiohydantoin-derivative standards eluted. The fact that no phenylthiohydantoin-lysine could be detected in cycle 4 together with the fact that tryptic hydrolysis was prevented at this site strongly suggests that modification had occurred at Lys67.

Site-directed Mutagenesis of Lys67

Lys67 was exchanged for alanine and arginine residues. The mutant enzymes were expressed in E. coli BL21(DE3), and recombinant enzyme content and activities in the bacterial membrane fractions were determined. K67A and K67R were expressed and recovered in the bacterial membrane. Both mutants displayed activities very similar to wild type microsomal GST (Table II). Thus, the possibility of Lys67 taking part in catalysis can be discounted. It is possible, however, that this residue is situated at or near the active site of the enzyme.

Mutation of Histidine and Tyrosine Residues

The three histidine residues of microsomal GST were replaced by glutamines, and mutants were expressed in E. coli. Specific activities of the mutants are shown in Table II. Neither mutation had any dramatic effect on activity. Histidine residues are thus proven nonessential for the microsomal GST.

Of the six tyrosines that were mutated to phenylalanine, none of the resulting mutants exhibited any significant loss of activity (Table II). Therefore, it can be concluded that a tyrosine residue is not acting in catalysis by stabilizing the GSH thiolate anion as in most cytosolic GSTs (excluding the Theta class). Y137F displays a higher activity than the wild type, implying a role in the stabilization of the unactivated conformation of microsomal GST.

Mutation of Cys49

Cys49 was replaced by an alanine residue, and the mutant was expressed and partially purified as described above. The elution profile of C49A was similar to the wild type microsomal GST, and a semipurified protein was obtained. Cys49 is clearly demonstrated as the site of activation with sulfhydryl reagents, since incubation with NEM did not affect the activity and function of C49A. The enzymatic properties of C49A are shown in Table III. C49A exhibits a "semiactivated" behavior compared with the unactivated and the NEM-activated wild type enzyme.

Table III.

Enzymatic properties of C49A

Values are means ± S.D. of >= 3 observations.


Substrate Specific activity kcat/Km

µmol/min-1 mg-1 mM-1 s-1
GSH + CDNB 10.2  ± 2.7 (2.6, 35)a
N-Acetyl-L-cysteine + CDNB 8.5  ± 2.2 (8.8, 2.6)
GSH + 4-chloro-3-nitrobenzamide 1.5  ± 0.9 (1.9, 1.9)
GSH 1.2  ± 0.04 (1.8, 9.5)
CDNB 520  ± 70 (270, 380)
N-Acetyl-L-cysteine 0.18  ± 0.02 (0.35, 0.10)

a Values in parentheses represent those obtained with the unactivated and NEM-activated wild type microsomal GST, respectively. Data are compiled from Refs. 30, 45, and 46.


DISCUSSION

Selective chemical reagents that covalently modify their targets can be useful in the screening of amino acid residues that are involved in catalysis and substrate binding. Inactivation of an enzyme by such reagents accompanied by protection against inactivation by competitive inhibitors for the enzyme is used as a criterion to assess whether modification is active site-directed. However, as is demonstrated here, and amply in the literature, in vitro mutagenesis shows that this is often not the case.

The arginine-selective reagent phenylglyoxal rapidly inactivates microsomal GST. Protection against inactivation is provided by the substrate analogue and competitive inhibitor glutathione sulfonate. About 2 mol of the radiolabeled reagent is incorporated in the unprotected enzyme, and the inhibitor prevents incorporation of approximately 1 mol of PG (Fig. 2). The stoichiometry of the reaction between PG and arginine residues in proteins has been suggested to be both 2:1 (42) and 1:1 (43), and thus it is difficult to determine whether one or two arginine residues are modified in the unprotected microsomal GST. However, since glutathione sulfonate prevented 50% of the incorporation while protecting from inactivation, it appears most likely that inactivation of microsomal GST by PG is the result of modification of one arginine residue. Peptic digests of [14C]PG-inactivated microsomal GST displayed very complicated patterns of small overlapping peptides making separation difficult. A substantially purified peptide contained the most extensively labeled residue, which was identified as Arg107. Exchange of Arg107 to alanine by site-directed mutagenesis gave a mutant protein that was expressed and recovered in the membrane of the bacterial host. Partially purified R107A displayed an activity and inhibition profile that is indistinguishable from the wild type enzyme. Clearly, Arg107 does not appear to directly participate in catalysis or substrate binding. Nevertheless, Arg107 might well be masked by bound glutathione sulfonate, indicating proximity to the active site, but the possibility of long range conformational stabilization cannot be excluded. The decreased thermostability of R107A indicates a structural role for this arginine. R107A is irreversibly inactivated at room temperature following a time course that closely resembles the inactivation of PG-modified wild type microsomal GST (Fig. 3). Reaction of wild type enzyme with PG also induces a thermosensitization that appears to be identical to that of R107A (Fig. 4). Both the thermoinactivated R107A and the PG-inactivated wild type are able to retain a substantial activity toward N-acetyl-L-cysteine, indicating a conformational change to a new, stable "low activity" form. The positive charge of the arginine side chain appears to be important, since replacement by lysine in R107K does not affect enzyme function. Therefore, it seems likely that an electrostatic interaction is important for maintaining the optimal conformation of the active site. The new low activity form might be amenable to structural analysis and could yield valuable insights into the structure-function relation of microsomal GST.

TNBS is a water-soluble lysine-selective reagent that is convenient for modification experiments because it allows direct monitoring of trinitrophenylation of lysine residues without the use of radioactivity. Since it can also react with cysteine thiols, the enzyme was pretreated with NEM to prevent modification of Cys49. Microsomal GST is very rapidly inactivated by trinitrophenylation. Inactivation, as well as modification of a lysine residue, is prevented by the inhibitor glutathione sulfonate. Tryptic digests of TNBS-inactivated microsomal GST yielded one extensively labeled peptide that, when glutathione sulfonate was present in the reaction, appeared only as a minor shoulder in the HPLC chromatogram. Amino acid sequence analysis of this peptide strongly suggested Lys67 as the modified residue, and the active site location of Lys67 appeared obvious.

Exchange of Lys67 to alanine and arginine by site-directed mutagenesis, however, yielded a different result than expected from the chemical modification experiments. Neither K67A nor K67R showed any noticeable change in enzymatic activity as compared with the wild type enzyme. Thus, it appears that Lys67 does not have any direct function in substrate binding or catalysis. It is possible, however, that Lys67 might be situated in close proximity to the active site so that the introduction of the relatively large and bulky trinitrophenyl group at the side chain of Lys67 induces an unfavorable conformation of the active site or simply blocks access. Exchange of this single residue by site-directed mutagenesis is a more subtle change that, in this case, had no effect on the function of the enzyme.

Chemical modification of microsomal GST also indicated the involvement of a histidine residue in catalysis (22). Mutation of the three histidine residues in microsomal GST did not yield any major alterations of activity and function. No essential functions are therefore assigned to histidine residues in microsomal GST.

When the tyrosine residues of microsomal GST2 were exchanged for phenylalanines, we expected to find a mutant that displayed a dramatically lowered turnover number, indicating a thiolate anion stabilizing function of a tyrosine hydroxyl group as in most cytosolic GSTs. However, none of the six Tyr right-arrow Phe mutants that were constructed exhibited such behavior. Thus, it appears that catalysis is carried out in a distinct way by the microsomal GST. A serine residue has recently been reported to fulfill a thiolate anion stabilizing function in a Theta class GST (26). Therefore, it is of interest to investigate the role of the serines/threonines in microsomal GST. It is interesting to note that Y137F was partially activated, making it a candidate for structural analysis of changes accompanying activation.

Microsomal GST is activated by sulfhydryl reagents, and Cys49 was therefore early implied as the target. One could expect that removal of the thiol would yield a constitutionally activated or an unactivable enzyme. Mutation of Cys49 to alanine yielded a semiactivated enzyme that had properties of both the unactivated and activated microsomal GST (Table III). Incubation of C49A with NEM did not have any effect on the activity with any of the substrates tested. Cys49 is therefore unequivocally demonstrated as the site of modification that results in activation. It is anticipated that more drastic amino acid changes yielding mutants that more resemble the NEM-modified protein would result in more fully activated enzyme species.

It is an attractive hypothesis that the microsomal GST can function as a quickly alerted defense against reactive, toxic electrophiles that, when these interact with Cys49, could be more readily detoxicated by the activated enzyme.

In conclusion, we have demonstrated an essential structural, noncatalytic role of Arg107 and the importance of Cys49 as the site of activation by sulfhydryl reagents. Lys67 and all histidine residues are not essential for catalysis. Furthermore, microsomal GST does not have an active site tyrosine residue assisting the activation of GSH like the majority of cytosolic GSTs. A distinct catalytic mechanism for the microsomal GST is therefore suggested.


FOOTNOTES

*   This work was supported in part by Swedish Cancer Society Projects 1806 and 2055, the Swedish National Board of Laboratory Animals, Swedish Medical Research Council Project 13X-10832, and funds from the Karolinska Institute.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   Supported by the Swedish Society for Medical Research.
   Supported by the Wenner-Gren foundation. Present address: Dept. of Biochemistry, Faculty of Medicine and Health sciences, U. A. E. University, P.O. Box 17666, Al Ain, United Arab Emirates.
**   To whom correspondence should be addressed: Inst. of Environmental Medicine, Division of Biochemical Toxicology, Karolinska Institutet, Box 210, S-171 77 Stockholm, Sweden. Tel.: 46-8-7287574; Fax: 46-8-334467; E-mail: ralf.morgenstern{at}imm.ki.se.
1   The abbreviations used are: GST, glutathione S-transferase; NEM, N-ethylmaleimide, PG, phenylglyoxal, TNBS, 1,3,5-trinitrobenzenesulfonate; PCR, polymerase chain reaction; HPLC, high pressure liquid chromatography; CDNB, 1-chloro-2,4-dinitrobenzene.
2   Tyrosine 18 was not exchanged, since it is known that residues 1-41 can be proteolytically removed from the enzyme that remains active (44).

ACKNOWLEDGEMENTS

We thank Ella Cederlund and Gunilla Lundquist at the Department of Medical Biochemistry and Biophysics for invaluable advice, help, and technical assistance with HPLC and amino acid sequence analysis of peptides.


REFERENCES

  1. Morgenstern, R., and DePierre, J. W. (1988) in Glutathione Conjugation: Its Mechanism and Biological Significance (Ketterer, B., and Sies, H., eds), pp. 157-174, Academic Press Ltd., London
  2. Mannervik, B., and Danielson, U. H. (1988) CRC Crit. Rev. Biochem. 23, 283-337 [Medline] [Order article via Infotrieve]
  3. Chasseaud, L. F. (1979) Adv. Cancer Res. 29, 175-274 [Medline] [Order article via Infotrieve]
  4. Mannervik, B. (1985) Adv. Enzymol. Relat. Areas Mol. Biol. 57, 357-417 [Medline] [Order article via Infotrieve]
  5. Meyer, D. J., Coles, B., Pemble, S. E., Gilmore, K. S., Fraser, G. M., and Ketterer, B. (1991) Biochem. J. 274, 409-414 [Medline] [Order article via Infotrieve]
  6. Tomarev, S. I., Zinovieva, R. D., Guo, K., and Piatigorsky, J. (1993) J. Biol. Chem. 268, 4534-4542 [Abstract/Free Full Text]
  7. Morgenstern, R., DePierre, J. W., and Jörnvall, H. (1985) J. Biol. Chem. 260, 13976-13983 [Abstract/Free Full Text]
  8. DeJong, J. L., Morgenstern, R., Jörnvall, H., DePierre, J. W., and Tu, C.-P. D. (1988) J. Biol. Chem. 263, 8430-8436 [Abstract/Free Full Text]
  9. Morgenstern, R., Guthenberg, C., and DePierre, J. W. (1982) Eur. J. Biochem. 128, 243-248 [Abstract]
  10. Andersson, C., Söderström, M., and Mannervik, B. (1988) Biochem. J. 249, 819-823 [Medline] [Order article via Infotrieve]
  11. McLellan, L. I., Wolf, C. R., and Hayes, J. D. (1989) Biochem. J. 258, 87-93 [Medline] [Order article via Infotrieve]
  12. Hebert, H., Schmidtkrey, I., and Morgenstern, R. (1995) EMBO J. 14, 3864-3869 [Abstract]
  13. Morgenstern, R., and DePierre, J. W. (1983) Eur. J. Biochem. 134, 591-597 [Abstract]
  14. Morgenstern, R., Lundqvist, G., Jörnvall, H., and DePierre, J. W. (1989) Biochem. J. 260, 577-582 [Medline] [Order article via Infotrieve]
  15. Aniya, Y. (1989) J. Pharmacobio-Dyn. 12, 235-240 [Medline] [Order article via Infotrieve]
  16. Aniya, Y., and Anders, M. W. (1989) J. Biol. Chem. 264, 1998-2002 [Abstract/Free Full Text]
  17. Sinning, I., Kleywegt, G. J., Cowan, S. W., Reinemer, P., Dirr, H. W., Huber, R., Gilliland, G. L., Armstrong, R. N., Ji, X. H., Board, P. G., Olin, B., Mannervik, B., and Jones, T. A. (1993) J. Mol. Biol. 232, 192-212 [CrossRef][Medline] [Order article via Infotrieve]
  18. Ji, X. H., Zhang, P. H., Armstrong, R. N., and Gilliland, G. L. (1992) Biochemistry 31, 10169-10184 [Medline] [Order article via Infotrieve]
  19. Reinemer, P., Dirr, H. W., Ladenstein, R., Huber, R., Lobello, M., Federici, G., and Parker, M. W. (1992) J. Mol. Biol. 227, 214-226 [Medline] [Order article via Infotrieve]
  20. Wilce, M. C. J., Board, P. G., Feil, S. C., and Parker, M. W. (1995) EMBO J. 14, 2133-2143 [Abstract]
  21. Ji, X. H., Vonrosenvinge, E. C., Johnson, W. W., Tomarev, S. I., Piatigorsky, J., Armstrong, R. N., and Gilliland, G. L. (1995) Biochemistry 34, 5317-5328 [Medline] [Order article via Infotrieve]
  22. Andersson, C., and Morgenstern, R. (1990) Biochem. J. 272, 479-484 [Medline] [Order article via Infotrieve]
  23. Liu, S., Zhang, P., Ji, X., Johnson, W. W., Gilliland, G. L., and Armstrong, R. N. (1992) J. Biol. Chem. 267, 4296-4299 [Abstract/Free Full Text]
  24. Kong, K. H., Takasu, K., Inoue, H., and Takahashi, K. (1992) Biochem. Biophys. Res. Commun. 184, 194-197 [Medline] [Order article via Infotrieve]
  25. Kolm, R. H., Sroga, G. E., and Mannervik, B. (1992) Biochem. J. 285, 537-540 [Medline] [Order article via Infotrieve]
  26. Board, P. G., Coggan, M., Wilce, M., and Parker, M. W. (1995) Biochem. J. 311, 247-250 [Medline] [Order article via Infotrieve]
  27. Andersson, C., Mosialou, E., Weinander, R., Hebert, H., and Morgenstern, R. (1993) in Structure and Function of Glutathione Transferases (Tew, K. D., Picket, C. B., Mantle, T. J., Mannervik, B., and Hayes, J. D., eds), pp. 109-116, CRC Press, Inc., Boca Raton, FL
  28. Weinander, R., Ekström, L., Raza, H., Lundqvist, G., Lindkvist, B., Sun, T.-H., Hebert, H., Schmidt-Krey, I., and Morgenstern, R. (1996) in Glutathione S-Transferases: Structure, Function and Clinical Implications (Vermeulen, N. P. E., Mulder, G. J., Nieuwenhuyse, H., Peters, W. H. M., and van Bladeren, P. J., eds), pp. 49-56, Taylor and Francis, London
  29. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
  30. Weinander, R., Anderson, C., and Morgenstern, R. (1994) J. Biol. Chem. 269, 71-76 [Abstract/Free Full Text]
  31. Habig, W. H., Pabst, M. J., and Jakoby, W. B. (1974) J. Biol. Chem. 249, 7130-7139 [Abstract/Free Full Text]
  32. Keen, J. H., Habig, W. H., and Jakoby, W. B. (1976) J. Biol. Chem. 251, 6183-6188 [Abstract]
  33. Haynes, R., Osuga, D. T., and Feeney, R. E. (1967) Biochemistry 6, 541-547 [Medline] [Order article via Infotrieve]
  34. Kaiser, R., Holmquist, B., Hempel, J., Vallee, B. L., and Jörnvall, H. (1988) Biochemistry 27, 1132-1140 [Medline] [Order article via Infotrieve]
  35. Weinander, R., Mosialou, E., Dejong, J., Tu, C.-P. D., Dypbukt, J., Bergman, T., Barnes, H. J., Höög, J. O., and Morgenstern, R. (1995) Biochem. J. 311, 861-866 [Medline] [Order article via Infotrieve]
  36. Inoue, H., Nojima, H., and Okayama, H. (1990) Gene (Amst.) 96, 23-28 [CrossRef][Medline] [Order article via Infotrieve]
  37. Sanger, F., Nicken, S., and Coulson, A. R. (1977) Proc. Natl. Acad. Sci. U. S. A. 74, 5463-5467 [Abstract]
  38. Studier, F. W. (1991) J. Mol. Biol. 219, 37-44 [Medline] [Order article via Infotrieve]
  39. Laemmli, U. K. (1970) Nature 227, 680-685 [Medline] [Order article via Infotrieve]
  40. Towbin, H., Staehelin, T., and Gordon, L. (1979) Proc. Natl. Acad. Sci. U. S. A. 76, 4350-4354 [Abstract]
  41. Peterson, G. L. (1977) Anal. Biochem. 83, 346-356 [Medline] [Order article via Infotrieve]
  42. Takahashi, K. (1968) J. Biol. Chem. 243, 6171-6179 [Abstract/Free Full Text]
  43. Borders, C. L., Riordan, J. F., and Vallee, B. L. (1975) Biochemistry 14, 4699-4704 [Medline] [Order article via Infotrieve]
  44. Andersson, C., Weinander, R., Lundqvist, G., Depierre, J. W., and Morgenstern, R. (1994) Biochim. Biophys. Acta 1204, 298-304 [Medline] [Order article via Infotrieve]
  45. Morgenstern, R., Lundqvist, G., Hancock, V., and DePierre, J. W. (1988) J. Biol. Chem. 263, 6671-6675 [Abstract/Free Full Text]
  46. Andersson, C., Mosialou, E., Adang, A. E. P., Mulder, G. J., van der Gen, A., and Morgenstern, R. (1991) J. Biol. Chem. 266, 2076-2079 [Abstract/Free Full Text]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.